7722 related articles for article (PubMed ID: 2622598)
1. [Characteristics of the immune status of patients with uveal melanoma during the performance of organ-preserving treatment].
Maletskiĭ AP; Vit VV; Vanichkin AA
Oftalmol Zh; 1989; (6):341-6. PubMed ID: 2622598
[TBL] [Abstract][Full Text] [Related]
2. [Immunoglobulins M, G and A as prognostic criteria of the treatment outcome in uveal melanoblastoma].
Kotelianskiĭ EO
Oftalmol Zh; 1989; (2):104-7. PubMed ID: 2755651
[TBL] [Abstract][Full Text] [Related]
3. [Management of a melanoma of the choroid or ciliary body].
de Jong PT
Ned Tijdschr Geneeskd; 1987 Mar; 131(11):439-43. PubMed ID: 3561548
[No Abstract] [Full Text] [Related]
4. Update on the management of posterior uveal melanoma.
Zhao DY; Shields CL; Shields JA; Gunduz K
J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
[TBL] [Abstract][Full Text] [Related]
5. [How should melanoma of the choroid or ciliary body be managed?].
Steggerda NF
Ned Tijdschr Geneeskd; 1987 Jun; 131(26):1144. PubMed ID: 3614397
[No Abstract] [Full Text] [Related]
6. [How should melanoma of the choroid or ciliary body be managed?].
Manschot WA
Ned Tijdschr Geneeskd; 1987 Mar; 131(12):504-5. PubMed ID: 3574504
[No Abstract] [Full Text] [Related]
7. [How to proceed in a case of choroid or ciliary body melanoma?].
Ned Tijdschr Geneeskd; 1987 May; 131(18):780-1. PubMed ID: 3587407
[No Abstract] [Full Text] [Related]
8. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
9. Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?
Jager MJ; Ly LV; El Filali M; Madigan MC
Prog Retin Eye Res; 2011 Mar; 30(2):129-46. PubMed ID: 21129496
[TBL] [Abstract][Full Text] [Related]
10. [Reaction of leukocyte migration inhibition in patients with uveal melanoblastoma].
Nifontova TP
Vopr Onkol; 1986; 32(4):57-61. PubMed ID: 3705529
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of intraocular melanoma: new concepts].
De Potter P
Bull Mem Acad R Med Belg; 2003; 158(1-2):103-11; discussion 111-2. PubMed ID: 12852096
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of uveal melanoma.
Shields JA; Shields CL; De Potter P; Singh AD
Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of eyeball and ocular appendages malignant tumors].
Iunusova GD
Vestn Oftalmol; 1999; 115(4):37-8. PubMed ID: 10523967
[TBL] [Abstract][Full Text] [Related]
14. [Study of the lymphocyte blast transformation reaction as a criterion of prognosis in the outcome of treatment of uveal melanoblastomas].
Kotelianskiĭ EO
Oftalmol Zh; 1986; (7):407-9. PubMed ID: 3493458
[No Abstract] [Full Text] [Related]
15. [Immunological aspects of malignant melanomas of the choroid].
Le Hoang P
Bull Soc Ophtalmol Fr; 1986 Nov; Spec No():143-51. PubMed ID: 3791545
[No Abstract] [Full Text] [Related]
16. [Conservative treatment of intraocular tumors in the adult].
Zografos L; Gailloud C
Ther Umsch; 1984 Apr; 41(4):278-80. PubMed ID: 6729760
[No Abstract] [Full Text] [Related]
17. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
Augsburger JJ; Corrêa ZM; Freire J; Brady LW
Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
[TBL] [Abstract][Full Text] [Related]
18. [Brachytherapy in choroidal melanoma].
Starzycka M; Słomska J; Romanowska B
Klin Oczna; 1999; 101(1):19-22. PubMed ID: 10401209
[TBL] [Abstract][Full Text] [Related]
19. [What to think of "adjuvant" or "neoadjuvant" thermotherapy in the treatment of uveal melanomas?].
Grange JD
J Fr Ophtalmol; 2001 Feb; 24(2):191-8. PubMed ID: 11240495
[TBL] [Abstract][Full Text] [Related]
20. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
